Trials / Completed
CompletedNCT03738358
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Trehalose in Patients With Fatty Liver Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study will be conducted to evaluate the efficacy and safety of trehalose in patients with fatty liver disease. After 12-week intake, subjects will be checked up fat content in liver using CT scan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Trehalose | 80 mL pouch/day for 12 weeks, containing trehalose 5 g, water 74.92 g and scent additive 0.08 g |
| OTHER | Placebo | 80 mL pouch/day for 12 weeks, containing water 79.92 g and scent additive 0.08 g |
Timeline
- Start date
- 2016-06-30
- Primary completion
- 2018-03-20
- Completion
- 2018-03-20
- First posted
- 2018-11-13
- Last updated
- 2019-01-30
Source: ClinicalTrials.gov record NCT03738358. Inclusion in this directory is not an endorsement.